Intravenous magnesium sulfate versus diltiazem in paroxysmal atrial fibrillation

International Journal of Cardiology

Volumn 79, Issue 2-3, 2001, Pages 287-291

  Chiladakis, John A ^a   Stathopoulos, Christos ^a   Davlouros, Periclis ^a   Manolis, Antonis S ^a,b  

^a UNIVERSITY OF PATRAS   (Greece)

^b NONE   (Greece)

Author keywords

Diltiazem; Magnesium sulfate; Paroxysmal atrial fibrillation

Indexed keywords

DILTIAZEM; MAGNESIUM SULFATE;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOSE TIME EFFECT RELATION; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEART ATRIUM FIBRILLATION; HEART RATE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINUS RHYTHM; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CALCIUM CHANNEL BLOCKERS; DILTIAZEM; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MAGNESIUM SULFATE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TACHYCARDIA, PAROXYSMAL;

EID: 0034924926     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(01)00450-8     Document Type: Conference Paper

References (16)

1. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation
2. Atrial fibrillation and stroke: Clinical presentation of cardioembolic versus atherothrombotic infarction
3. Acute treatment of atrial fibrillation: Spontaneous conversion rates and cost of care
4. Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter
5. Safety and efficacy of intravenous diltiazem in atrial fibrillation or atrial flutter
6. Cardiodepressant potency of various calcium channel antagonists in human myocardium
7. Digoxin for converting recent-onset atrial fibrillation to sinus rhythm: A randomized, double-blinded trial
8. Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: The effect of digoxin
9. Effects of magnesium sulfate on cardiac conduction and refractoriness in humans
10. The electrophysiological effects of intravenous magnesium on human sinus node, atrioventricular node, atrium, and ventricle
11. Parenteral magnesium sulfate versus amiodarone in the therapy of atrial tachyarrhythmias: A prospective, randomized study
12. The effect of magnesium versus verapamil on supraventricular arrhythmias
13. Magnesium therapy in new-onset atrial fibrillation
14. Effect of magnesium sulfate on ventricular rate control in atrial fibrillation
15. Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm
16. Effect of intravenous magnesium sulfate on supraventricular tachycardia